Inactivation of Bcl-2 by phosphorylation - PubMed (original) (raw)

Inactivation of Bcl-2 by phosphorylation

S Haldar et al. Proc Natl Acad Sci U S A. 1995.

Abstract

The antiapoptosis potential of Bcl-2 protein is well established, but the mechanism of Bcl-2 action is still poorly understood. Using the phosphatase inhibitor okadaic acid or the chemotherapeutic drug taxol, we found that Bcl-2 was phosphorylated in lymphoid cells. Phospho amino acid analysis revealed that Bcl-2 was phosphorylated on serine. Under similar conditions, okadaic acid or taxol treatment led to the induction of apoptosis in these cells. Thus, phosphorylation of Bcl-2 seems to inhibit its ability to interfere with apoptosis. In addition, phosphorylated Bcl-2 can no longer prevent lipid peroxidation as required to protect cells from apoptosis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Annu Rev Biochem. 1989;58:453-508 - PubMed
    1. Exp Cell Res. 1991 Jul;195(1):237-46 - PubMed
    1. Arch Biochem Biophys. 1994 Dec;315(2):483-8 - PubMed
    1. Cancer Res. 1994 Apr 15;54(8):2095-7 - PubMed
    1. Nature. 1980 Apr 10;284(5756):555-6 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources